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ABSTRACT  
Sorption of 75 active pharmaceutical ingredients (APIs) to three different types of sludge 
(primary sludge, secondary sludge with short and long sludge age respectively) was investigated. 
To obtain the sorption isotherms batch studies with the APIs mixture were performed in four 
nominal concentrations to water containing 1 g of sludge. The range of APIs concentrations was 
between ng L-1 to µg L-1 which is found in the wastewater effluent. Isotherms were obtained for 
approximately 45 of the APIs, providing distribution coefficients for linear (Kd), Freundlich (Kf) 
and Langmuir (KL) isotherms. Kd, Kf and KL ranging between 71-3.8×104, 1.1×10-5- 61 and 
9.2×10-6- 1.1×10-3L g-1, respectively.  The obtained coefficients were applied to estimate the 
fraction of API in the water phase (see Abstract Graphic). For 37 of the 75 the APIs predicted 
presence in the liquid phase was estimated to > 80%.  24 APIs were estimated to be present in 
the liquid phase between 20 - 80 %, and 14 APIs were found to have < 20% presence in the 
liquid phase, i.e. high affinity towards sludge. Furthermore, the effect of pH at values 6, 7 and 8 
was evaluated using one way ANOVA-test. A significant difference in Kds due to pH changes 
was found for 6 of the APIs (variation 10-20%). 
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NOMENCLATURE See Table S1, supplementary data. 
1. Introduction 
The presence of human and veterinary pharmaceuticals in the environment has been recognized 
as a potential environmental threat (Ternes et al., 2002). After their use, pharmaceutical are 
either excreted unchanged or as metabolites via urine and faeces or are washed off and 
subsequently reach a wastewater treatment plant (WWTP) via the sewage system. The active 
pharmaceutical ingredients (APIs) are designed to have pharmacological effects at low 
concentrations, which have lead to concerns regarding their distribution in aquatic environments 
and potential non-wanted biological effects in different organisms. 
APIs have been found in several environmental compartments such as waste, surface and ground 
waters (Calisto and Esteves, 2009; Fick et al., 2009; Gabet-Giraud et al., 2010; Lindberg et al., 
2010), as well as in sludge and sediments (Ternes et al., 2002; Andersen et al., 2003). Sorption of 
APIs to sludge, during wastewater treatment processes in which sludge is separated from the 
wastewater stream may be an important factor for the removal of non-biodegradable 
pharmaceuticals from WWTPs.  
Solid matter is separated from wastewater during treatment. After the separation of incoming 
particles, the remaining organic material is generally biologically removed in an activated sludge 
system. After treatment, sludge is separated from the treated water by a second sedimentation 
step. If extended nitrogen removal is required, biological nitrogen removal is implemented.  In 
colder regions, nitrogen removal is not needed and only biological oxygen demand (BOD) is 
removed. Thus the sludge age can be shorter. The pH of wastewater during the treatment process 
is typically close to 7, within the range of 6.0-8.0 which likely results in minor property changes. 
Surveys in which pKa (acid- ionization constant) have been determined, reported  pKa  values of 
5.3 and 9.5 for dissolved organic matter (DOM) in the sludge (Wang et al., 1998) and 6.1 for 
sludge particles (Wang et al., 2000). For the APIs however, the pH may change the effect of 
sorption, especially for APIs with pKa or pKb (base-ionization constant) within pH range of 6-8. 
The effect of pH on the sorption of APIs has been discussed by other studies (Ternes et al., 2004; 
Jones et al., 2006;  Carballa et al., 2008) but without firm conclusions. However, studies have   
shown that for acidic compounds, such as Ibuprofen and Diclofenac the distribution between 
water and solid phase is affected by pH changes. At pH 4, which is below the pH values found in 
WWTP, the distribution coefficient (Kd) increased compared to the Kd obtained at the pH 7 
(Urase and Kikuta, 2005). Kd may be experimentally determined or calculated from the octanol-
water distribution coefficient (Kow). Stuer-Lauridsen et al., (2000) provides thoroughly described 
estimations of Kd based on Kow where pKa and the fraction of organic carbon are considered. 
Also Radjenović et al., (2009) calculated Kd values for APIs ranging between 0.4-16 859 L kg-1. 
Experimental determination of Kd may be conducted in continuous or batch experiments. In 
order to obtain Kd values during continuous experiments several different parameters need to be 
known, such as the order of biodegradation, rate of sorption and rate of desorption. In batch 
experiments, biodegradation is eliminated by adding sodium azide or some other toxic substance, 
however the ion strength changes which may affects the APIs sorption. A third option is to 
freeze dry the sludge gently, this will preserve the tertiary structure of the sludge. Thereafter heat 
the sludge to 103°C in order to sterilize the sludge. This procedure was used by Andersen et al, 
(2005). In a continuous experiment Kd values were determined for antiepileptic, antiphlogistic, 
antibiotic, estrogens, contrast medium. (Carballa et al., 2008) However, these studies cover a 
rather low number of the APIs available on the market and the experimentally obtained Kd 
values ranges from negligibly to log Kd 4.43 (Carballa et al., 2008). 
The objective of this study was to experimentally determine Kd values for 75 selected APIs. The 
Kd values were obtained from sorption isotherms in three different types of sludge, primary 
sludge, and secondary sludge with long and short sludge age, respectively. The obtained Kd 
values were used to estimate the removal of APIs by sorption to sludge in WWPTs. Furthermore, 
the influence on sorption caused by normal pH variations (pH 6-8) found in WWTPs was 
investigated. This study was based on a straightforward approach using fixed nominal 
concentrations of each API in water mixed with a known amount of sterilized sludge in order to 
determine the sorption distribution coefficients.  
2. Materials and methods 
2.1. Sludge  
Sludge was collected from three WWTPs which were representative of WWTPs in Sweden and 
other industrialised countries for treatment of municipal wastewater.  
Primary sludge was collected from Avedøre WWTP, which treats wastewater corresponding to 
275 000 person equivalents (PE) from 10 municipalities in the southern part of Greater 
Copenhagen, Denmark. It was chosen since it was possible to collect primary sludge without 
contamination from internal recirculation of secondary sludge. Suspended solids (SS) and 
volatile suspended solid (VSS) were 43 and 35 g L-1, respectively. Secondary sludge with a long 
sludge age and nitrification was collected from Klagshamn WWTP. This plant treats municipal 
wastewater corresponding to about 60 000 PE from the southern part of Malmö City, Sweden 
and a nearby municipality. The plant uses primary precipitation and nitrification in activated 
sludge (sludge content 3 g L-1). SS and VSS were 4 and 3 g L-1, respectively.  Denitrification 
took place in a post-denitrifying, moving bed biofilm reactor. Biological sludge with short sludge 
age was collected from Sjölunda WWTP. This is typical for plants in the north and in many 
inland cities in Sweden. The plant treats wastewater corresponding to approximately 315 000 PE 
from Malmö city, Sweden and surrounding municipalities. The plant was operated with 
combined primary and simultaneous precipitations. Removal of organic matter took place in a 
highly loaded activated sludge plant where sludge was collected (sludge content 6 g L-1). SS and 
VSS were 8 and 6 g L-1, respectively.  Nitrification took place in a fixed bed trickling filter and 
denitrification in a moving bed biofilm reactor.  
Each portion of sludge was washed twice with tap water, decanted in order to remove water 
soluble constituents and frozen at -18ºC after sample collection. The sludge was gently freeze 
dried in order to preserve the structure and sterilized by heating at 103 ºC for minimum 3 h.  
2.2. Experimental design 
Nominal concentrations of the 75 APIs (see Table 1) included in the experiments were chosen 
based on the solubility, limit of quantification (LOQ) and linear range of the analytical method 
(Grabic et al., unpublished data; Fick et al., 2009). Volatilisation was considered and Henry’s 
Law constant (KH; Table S2 supplementary data) was calculated EPI Suite software HenryWin 
v3.10. All APIs had a KH <9×10-7 Atm·m3mol-1, therefore volatilisation would be insignificant, 
since only compounds with KH >3×10-3 are considered to be volatile (Ternes and Joss, 2008). 
The aim was to get four API equilibriums with water concentration (Cw; g L-1) in the range of 90 
% of the starting concentration (C0; g L-1) and the LOQ. The water solubility should be larger 
than the starting concentration; Cw << C0; LOQ< Cw. Sludge concentration in the experiments 
was 1 g/L, with exception for one sludge where it was increased to 10 and 50 g L-1 (Table 1). 
The 1 g L-1 sludge density was about 5- to 10-fold more than the realistic sludge production that 
can occur in a WWTP which ensures that APIs that adsorb significantly to sludge in a real 
WWTP also would be removed significantly from the water phase in the batch experiment which 
was the basis for determining a Kd-value, while low sorbing APIs Kds will not be determined 
A stock solution including the 75 API of 0.1g×L-1 was prepared in MeOH from which the four 
MeOH stock solutions of 0.4, 2.0, 10.0 and 50.0 ng µL-1 were prepared, respectively. These stock 
solutions suited the design (Table 1) and were theoretically determined to fit the criteria for the 
present study. Böhm and During (2010) showed that there was no significant difference between 
determination of the distribution coefficient KDOC for single compounds or mixtures. 
Artificial media was used in the study for the water phase (Berg and Nyholm, 1996), modified as 
described by Andersen et al. (2005). Fundamentally, the artificial sewage was a phosphate-
buffered mineral media containing Ca2+, K+, Mg2+, Na+, Cl- and SO42-.  
Sludge was added to 1 L borosilicate glass bottles. In order to inhibit microbial growth oxygen 
was removed by purging with N2(g) for 1 min and Na2SO3 was added to a final concentration of 
50 mg L-1 to each bottle. The bottles were left on stirring in the dark at + 4 ºC in order for the 
sludge to rehydrate. After 12 h, 200 µL of the API stock solutions of 0.4, 2.0, 10.0 or 50.0 ng µL-
1
 were added to the bottles using a Hamilton syringe giving the final concentrations presented in 
Table 1. The bottles were left on stirring in the dark at + 4 ºC for 12 h. Experiments were 
performed at three pH values (Table 1). The pH 7.0 was chosen based on a typical pH in 
WWTPs and pH 6.0 and 8.0 were based on low and high values from WWTPs. Control batches 
without APIs in the sludge and standard APIs solutions were prepared (Table 1).  
 
 
 
 
Table 1. The experimental set up, including API concentrations, pH sludge concentration and the number of bottles 
per blank/zero sludge/sludge. From each bottle triplicate solid phase extractions (SPE) were made. 
 API conc. (µg×L-1) pH Sludge conc. (g×L-1) No. of bottles 
Blank for each sludge 0 7 1 3 
No sludge 
 
0.08 0.4 2 10 7 0 4 
Primary sludge Avedøre  
 
0.08 0.4 2 10 7 1 4 
Secondary sludge short sludge age Sjölunda 
 
0.08 0.4 2 10 7 1 4 
10 10 1 
10 50 1 
Secondary sludge long sludge age Klagshamn  10 6 1 1 
0.08 0.4 2 10 7 4 
10 8 1 
 
Table 2. Sorption isotherms obtained during sorption to primary sludge. P is the significance that the linear model 
has a better fit than another model tested, the model tested was Freundlich and Langmuir.  
  Linear model   Freundlich model   Langmuir model 
 Kd   R2  Kf   n  R2  P τMAX KL R2  P  
 L kg-1   %  L g-1   %  % L g-1   %  % 
Afluzosin 1.8×103 99 2.7 1.1 99 42 5.5×104 3.7×10-5 99 31 
Amitryptiline 4.1×103 98 3.1 0.96 98 70 no fit    
Atenolol 4.6×102 88 4.0 1.3 91 17 5.7×103 1.4×10-4 90 18 
Atracurium 3.5×102 100 0.24 0.96 100 40 no fit    
Azelastine 6.4×103 82 46 1.4 86 11 2.0×104 5.8×10-4 89 3.5 
Biperiden 8.2×102 88 1.3 1.1 88 83 2.4×104 4.6×10-5 89 46 
Bupropion 85 98 4.8×10-3 0.76 99 0.99 no fit    
Chloprothixene 3.8×104 98 8.3 0.77 99 0.98 no fit     
Citalopram 5.4×102 76 0.97 1.1 76 83 1.0×104 6.7×10-5 7.7 59 
Clomipramine 1.7×104 99 7.6 0.88 99 8.5 no fit     
Clonazepam 5.7×102 96 0.10 0.84 96 33 no fit     
Clotrimazol 3.2×104 91 19.0 0.92 92 59 no fit     
Cyproheptadine 1.1×104 98 2.2 0.81 91 30 no fit    
Desloratidine 3.7×103 99 1.9 0.92 100 17 no fit    
Dicycloverin 1.4×103 92 1.2 0.98 94 90 6.2×104 2.7×10-5 94 66 
Donepezil 3.6×103 96 10.4 1.2 96 21 1.9×104 2.6×10-4 97 7.3 
Duloxetine 1.3×104 77 30.8 1.2 78 53 1.6×104 1.1×10-3 79 37 
Etonogestrel no fit      no fit    
Ezetimibe 2.3×103 97 4.9×10-2 0.68 99 1.1 no fit    
Fexofenadine 2.7×103 82 1.1×10-5 0.38 94 0.15 no fit    
Fluoxetine 1.0×104 99 2.7 0.83 99 3.6 no fit    
Flutamide 1.5×103 88 0.13 0.77 90 27 no fit    
Glibenclamide 3.6×103 77 no fit    no fit    
Glimepiride 2.1×103 92 1.9×10-3 0.53 97 0.8 no fit    
Haloperidol 1.0×104 76 60.9 1.4 80 21 1.5×104 1.2×10-3 81 12 
Hydroxyzine 1.2×103 98 3.2 1.1 99 14 1.9×104 8.3×10-5 99 16 
Irbesartan 7.0×102 92 1.5×10-2 0.70 93 19 no fit    
Ketoconazole 9.7×103 88 1.6 0.79 90 30 no fit    
Loperamide 1.4×104 98 0.60 0.69 99 0.04 no fit     
Maprotiline 6.7×103 99 1.7 0.83 100 0.05 no fit     
Megesterol no fit      no fit     
Mianserin 3.0×103 81 12.5 1.2 83 36 1.6×104 2.9×10-4 85 17 
9 
 
Nefazodone 1.4×104 98 2.7 0.79 99 4.0 no fit    
Oxazepam 7.9×102 90 0.80 1.0 90 99 2.1×104 4.3×10-5 90 71 
Paroxetine 1.4×104 96 5.6 0.87 97 28 no fit    
Pizotifen 4.7×103 100 no fit    no fit    
Progesterone 7.5×102 98 0.18 0.86 99 14 no fit    
Repaglinide 1.7×102 94 1.4 1.3 95 19 7.6×103 2.8×10-5 94 53 
Risperidone 1.9×103 99 3.1 1.1 99 36 3.2×104 7.0×10-5 99 17 
Sertraline 3.5×104 97 4.1 0.72 99 0.4 no fit     
Sulfamethoxazol 3.2×102 77 0.91 1.1 77 79 8.6×103 5.4×10-5 78 58 
Telmisartan 1.3×103 100 0.86 0.95 100 51 no fit    
Tramadol 1.1×102 94 4.9×10-4 0.63 96 3.3 no fit    
Trimethoprim 3.9×102 98 0.43 1.0 98 91 3.7×104 1.1×10-5 98 73 
Verapamil 1.8×103 99 1.1 0.94 99 26 no fit    
 
Table 3. Sorption isotherms obtained during sorption to secondary sludge long sludge age P is the significance that 
the linear model has a better fit than another model tested, the model tested was Freundlich and Langmuir. 
 Linear model Freundlich model Langmuir model 
 Kd  R2  Kf n  R2  P τMAX KL R  P  
 (L kg-1) (%) (L g-1)   (%) (%) (L g-1)  (%) (%) 
Afluzosin 1.2×103 100 2.2 1.1 100 4.0 3.7×104 4.0×10-5 100 1.3 
Alprazolam 7.4×102 94 1.6×10-2 0.69 96 4.6 no fit    
Amitryptiline 2.8×103 99 1.9 0.95 100 40 no fit    
Atenolol 1.6×103 94 22 1.5 99 0.0 7.8×103 4.9×10-4 99 0.0 
Atracurium 4.7×102 100 0.37 0.97 100 40 no fit    
Azelastine 2.0×103 99 3.2 1.1 99 31 5.8×104 3.9×10-5 99 22 
Biperiden 7.5×102 98 0.13 0.84 98 7.7 no fit    
Bisoprolol 1.1×102 -4.4 46 3.0 68 0.14 9.9×102 1.3×10-3 86 0.0 
Bupropion 1.4×102 99 0.35 1.1 100 4.2 5.3×103 3.5×10-5 100 1.4 
Chloprothixene 2.0×104 98 9.4 0.89 99 14 no fit    
Citalopram 2.1×102 94 0.90 1.2 95 25 3.8×103 8.1×10-5 95 20 
Clomipramine 6.7×103 100 3.4 0.91 100 1.4 no fit    
Clotrimazol 3.4×104 96 4.5 0.73 98 2.2 no fit    
Cyproheptadine 3.6×103 100 3.7 1.0 100 93 no fit    
Desloratidine 2.9×103 100 2.1 0.96 100 40 no fit    
Dicycloverin 1.7×103 99 0.50 0.88 99 13 no fit    
Donepezil 9.7×102 99 4.6 1.2 100 0.0 1.0×104 1.5×10-4 100 0.0 
Duloxetine 2.9×103 98 2.8 1.0 98 98 no fit    
Eprosartan 71 93 0.43 1.2 94 38 1.8×103 6.6×10-5 94 32 
Estradiol no fit    0.0      
Etonogestrel no fit    0.0      
Ezetimibe 3.0×103 96 3.0×10-2 0.63 99 0.0 no fit    
Fexofenadine 3.6×102 95 0.2 0.93 96 74 no fit    
Fluoxetine 6.0×103 99 1.3 0.83 100 0.80 no fit    
Flutamide 7.5×102 90 1.5×10-4 0.50 96 0.13 no fit    
Glibenclamide 1.3×103 93 0.2 0.82 99 8.2 no fit    
Glimepiride 9.6×102 99 0.2 0.83 99 11 no fit    
Haloperidol 2.9×103 98 3.5 1.0 98 78 1.1×105 2.8×10-5 98 76 
Hydroxyzine 7.2×102 98 0.54 0.97 98 68 no fit    
Irbesartan 9.4×102 94 5.3×10-4 0.54 97 1.2 no fit    
Ibuprofen 3.6×102 91 1.6×10-2 0.73 94 38 no fit    
Ketoconazole 8.5×103 91 0.70 0.73 95 0.8 no fit    
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Levonorgestrel 2.6×102 61 18 1.9×103 81 1.4 1.9×103 6.6×10-4 87 0.23 
Loperamide 5.5×103 97 0.53 0.77 98 0.83 no fit    
Maprotiline 4.5×103 99 0.65 0.79 100 0.05 no fit    
Medroxyprogesterone 1.7×102 42 15 2.1 56 11 1.3×103 6.4×10-4 60 6.1 
Megesterol 5.9×102 82 6.7 1.4 85 16 5.3×103 2.4×10-4 87 7.1 
Mianserin 9.1×102 99 1.4 1.1 99 45 2.6×104 4.0×10-5 99 29 
Nefazodone 8.3×103 96 0.96 0.76 98 1.6 no fit    
Orphenadrine 6.4×102 99 0.12 0.84 98 2.6 no fit    
Oxazepam 1.1×103 87 11 1.4 91 9.2 6.5×103 3.6×10-4 92 5.2 
Paroxetine 8.3×103 97 0.63 0.73 98 0.07 no fit    
Pizotifen 3.1×103 100 1.9 0.94 100 26 no fit    
Progesterone 1.1×103 87 8.6 1.3 90 17 7.4×103 2.9×10-4 92 5.4 
Repaglinide 2.1×102 17 10 1.8 98 0.0 2.7×103 2.8×10-4 99 0.0 
Risperidone 6.5×102 98 2.8 1.2 99 1.1 8.9×103 1.2×10-4 99 0.15 
Sertraline 1.7×104 92 1.3 0.71 97 1.3 no fit    
Sotalol 3.6×102 99 0.56 1.1 99 35 1.3×104 3.3×10-5 99 14 
Sulfamethoxazol 3.7×102 96 5.2×10-3 0.68 98 5.6 no fit    
Telmisartan no fit          
Tramadol 1.9×102 99 9.0×10-2 0.92 99 39 no fit    
Trimethoprim 4.2×102 99 0.18 0.91 99 16 no fit    
Venlafaxine 1.0×102 85 0.77 1.3 86 32 2.1×103 7.9×10-5 0.0 25 
Verapamil 4.0×102 84 20 1.8 96 0.0 3.3×103 4.3×10-4 98 0.0 
 
Table 4. Sorption isotherms obtained during sorption to secondary sludge short sludge age. P is the significance that 
the linear model has a better fit than another model tested, the model tested was Freundlich and Langmuir.  
 Linear model Freundlich model Langmuir model 
 Kd  R2  Kf  n  R2  P τMAX KL R2  P  
 (L kg-1)  (% ) (L g-1)   (%) (%) (L g-1)  (%) (%) 
Alprazolam 4.3×102 80 no fit        
Amitryptiline 2.8×103 96 4.2×10-2 0.66 98 0.27 no fit    
Atenolol 1.9×103 100 no fit        
Atracurium 6.1×102 98 2.9×10-2 0.73 99 0.1     
Azelastine 1.4×103 96 1.7×10-2 0.65 99 0.0 no fit    
Biperiden 8.4×102 96 0.13 0.82 96 26 no fit    
Bisoprolol 94 64 7.5 2.0 79.6 2.0 1.1×103 3.4×10-4 81 1.2 
Bupropion 2.0×102 97 1.9×10-2 0.79 98 6.2 no fit    
Chloprothixene no fit          
Clomipramine 7.3×103 88 6.0×10-3 0.49 97 0.0 no fit    
Clotrimazol no fit          
Cyproheptadine 5.3×103 97 0.23 0.70 99 0.0 no fit    
Desloratidine 3.2×103 96 0.10 0.69 99 0.22 no fit    
Dicycloverin 1.7×103 97 0.11 0.75 98 3.1 no fit    
Diltiazem 4.4×102 100 0.65 1.0 100 35 5.2×104 9.2×10-6 100 27 
Duloxetine 3.2×103 80 1.7×10-5 0.37 99 0.0 no fit    
Estradiol 2.3×102 72 0.16 0.97 72 93 1.6×104 1.6×10-5 72 85 
Etonogestrel 2.4×102 73 0.11 0.92 73 87 no fit    
Ezetimibe 8.5×103 87 0.72 0.98 87 91 9.4×104 1.0×10-4 87 65 
Fexofenadine 6.7×102 94 2.5×10-3 0.60 98 0.54 no fit    
Fluoxetine 5.7×103 91 1.4×10-3 0.47 99 0.0 no fit    
Flutamide 1.2×103 93 1.6×10-4 0.49 99 0.0 no fit    
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Glibenclamide 2.3×103 97 0.16 0.75 98 1.2 no fit    
Glimepiride 2.6×103 94 9.1×10-2 0.70 94 2.0 no fit    
Haloperidol 1.7×103 98 0.90 1.0 96 75 no fit    
Hydroxyzine 6.0×102 95 0.27 0.91 95 56 no fit    
Irbesartan no fit          
Ibuprofen 2.0×102 80 1.1 1.3 81 62 2.4×103 1.3×10-4 82 56 
Ketoconazole no fit          
Levonorgestrel no fit          
Loperamide 1.1×104 91 0.16 0.62 96 0.88 no fit    
Maprotiline 3.9×103 91 9.3×10-2 0.66 95 3.1 no fit    
Medroxyprogesterone 2.5×102 96 0.46 1.1 96 65 9.7×103 3.0×10-5 96 59 
Megesterol 8.3×102 86 0.30 0.89 86 66 no fit    
Mianserin 5.2×102 94 6.6×10-2 0.80 95 22 no fit    
Nefazodone 8.9×103 92 3.0×10-2 0.54 99 0.0 no fit    
Orphenadrine 5.4×102 98 0.17 0.88 98 25 no fit    
Oxazepam 1.6×103 97 3.1 1.1 97 40 2.3×104 8.7×10-5 98 33 
Paroxetine 8.6×103 82 5.6×10-5 0.37 98 0.0 no fit    
Pizotifen 3.1×103 98 0.20 0.74 1005 0.0 no fit    
Progesterone 1.1×103 96 0.21 0.83 96 20 no fit    
Repaglinide 5.1×102 98 1.3 1.1 98 28 2.5×104 2.4×10-5 98 44 
Risperidone 3.3×102 98 0.15 0.92 98 45 no fit    
Sertraline no fit          
Sotalol 7.4×102 99 0.22 0.87 99 6.3 no fit    
Sulfamethoxazol 2.8×102 95 no fit    no fit    
Telmisartan no fit          
Trimethoprim 2.8×102 98 1.3×10-2 0.75 100 0.15 no fit    
Verapamil 6.3×102 96 0.90 1.0 96 75 3.3×104 2.1×10-5 96 63 
 
2.3. Extraction and chromatography  
Triplicate extractions were made from each 1 L borosilicate glass bottle. After 12 h of stirring, 
the samples were allowed to stand for 30 minutes in order to let the sludge settle. In order to 
remove particles, the liquid phase was decanted and filtered through a glass microfiber filters 
(GC/F; VWR Denmark). In the filtered samples (100 g) a surrogate standard mixture was added 
followed by solid phase extraction using OASIS HLB (6cc, Waters, Sweden). A detailed 
description of sample preparation and analyses employing the LC-MS/MS methodology reported 
in Grabic et al., (unpublished data) and Fick et al., (2009) may be found as supplementary data 
S1.    
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2.4. Data analysis  
The measured concentrations of APIs in the water phase (C0) where no sludge was added and 
when sludge was added (Cw) and SS were used to calculate Cs as follows in each experimental 
replicate: 
Cs= (C0 - Cw)/SS   (Eq. 1) 
The sorption isotherms define the equilibrium between the concentration of a chemical in 
aqueous and solid phases (Schwarzenbach et al., 2003). With batch sorption experiments 
including multiple concentrations, sorption isotherms may be constructed, from which the solid-
water distribution coefficients can be determined. Three equations are used here to describe the 
sorption isotherms; linear (Eq. 2), Freundlich (Eq. 3) and Langmuir (Eq. 4). Cs is the 
concentration sorbed to the sludge (g kg-1) and Kd is the linear sorption constant. Kf is the 
Freundlich coefficient and n is the Freundlich exponent. τ represents the total number of surface 
sites per mass of sorbent and KL is the Langmuir coefficient.   
Linear wds CKC *=                  (Eq. 2)                              
Freundlich nws CKfC
1
*=             (Eq. 3) 
Langmuir 
wL
wL
s CK
CKC
*1
**max
+
=
τ
   (Eq. 4) 
The linear isotherm is the simplest case where the affinity of the API remains constant over the 
concentration interval. The Langmuir isotherm may have the best fit in cases where the sorbent 
becomes saturated at higher concentrations of API. Freundlich, is commonly employed to 
describe experimentally obtained sorption data (Schwarzenbach et al., 2003).  
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The software GraphPad Prism 5 for Windows (GraphPad Software, Inc.) was used for data 
evaluation, using a 95 % confidence interval for the best fit sorption isotherms. The two 
hypotheses tested were whether the linear isotherm was a better fit than the Freundlich isotherm, 
and whether the linear was a better fit compared to Langmuir isotherm. Furthermore, in order to 
qualify as the best fit the R2-value for the curve should be >0.7, otherwise no fit was made. 
2.5. Estimation of the sorbed fraction 
The estimation of the sorbed fraction of each API was made by employing the obtained Kd-
values (Table 2 to 4). In those cases where both Freundlich and Langmuir isotherms were found 
to have a better fit than the linear, the one with the best significance was chosen as the best fit. 
For the APIs where the Freundlich or Langmuir isotherm gave the best fit (see Table 2 to 4), Kd-
values were calculated for a water concentration of 1 µg L-1. The fraction of the APIs at 
equilibrium for a given sludge concentration (SS; kg L-1) was calculated using the Kd-values (L 
kg-1) according to equation 5.  
Sorbed fraction (FS) = 1-Fw= 
SW
S
CSSC
C
×+
 =
d
d
KSS
KSS
×+
×
1
 (Eq. 5)  
Furthermore, if the mass of the sludge removed from the WWTP per volume of treated sewage 
(RESS; kg L-1) is known, the fraction of the total APIs load into the activate sludge tank which 
would not be lost either by degradation or stripping, but that will be removed at equilibrium can 
be calculated as shown in equation 6. 
Removed fraction (FR) =
d
d
KRESS
KRESS
×+
×
1
  (Eq. 6) 
The sludge production from treatment of municipal sewage can be considered reasonably 
constant irrespective of the methods of treatment. Based on Henze et al. (2002) the typical 
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amounts of sludge removed from a WWTP can be calculated for primary and secondary sludge. 
For a WWPT with 2 h of settling time, the removal of primary sludge was estimated to 210 g m-3 
of treated wastewater. In order to estimate the removal of secondary sludge, the yield coefficient 
for a low load treatment plant was employed giving a removal of 110 g m-3 for the secondary 
sludge. The corresponding value for a high load treatment plant would be 165 g m-3.  
3. Results and discussion  
3.1 Sludge properties 
An ocular inspection of the freeze dried sludge showed that the primary sludge may be described 
as wadding, whereas the two types of secondary sludge had an appearance as instant coffee. The 
ocular differences between the different types of sludge may be due to their origin. Primary 
sludge settable particles of wastewater include faeces, toilet paper particles of food, and 
secondary sludge consist of bacteria biomass and biopolymers created by bacteria. It is likely 
that the mainly plant/wood derived primary sludge has different densities of functional groups 
and aromatic rings compared to the bacteria derived secondary sludge.   
3.2 Sorption isotherms  
Due to analytical limitations and the experimental conditions it was possible to determine 
sorption isotherms for 44-52 APIs (Table 2 to 4) out of the 75 APIs (Table S2). The linearly 
obtained Kd values ranged from 85 to 38 400, 199 to 11 340 and 71 to 34 050 L kg-1 for primary 
sludge, secondary sludge with short sludge age and secondary sludge with long sludge age, 
respectively. 
The sorption isotherm with the best fit was predominantly linear followed by the Freundlich 
isotherm (Table 2 to 4) within the studied concentration range (0.08-10 µg L-1). Examples of the 
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obtained isotherms are shown in Figure 1. Table 2 to 4 presents for 1 g L-1 sludge the obtained 
distribution coefficients, Freundlich coefficient, Freundlich exponent, τmax and Langmuir 
coefficient in the cases where the isotherms fitted these isotherm descriptions. Table 2 to 4 
exhibit the order of significance for each hypothesis tested.  
 
 
Figure 1. Example of the obtained sorption isotherms. From the top Pizotifen linear isotherm, second Maprotiline 
Freundlich isotherm and at the bottom Bisoprolol Langmuir isotherm. 
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The isotherms coefficients did not change significantly even at the higher sludge densities (Table 
S3). The average difference between the Kd’s obtained from 1 g L-1 sludge compared to the Kd 
obtained, when 10 and 50 g L-1 sludge was 4%. 
3.3 Sorption results and literature comparison  
As mentioned before for some of the APIs the sorption isotherms were not obtained under our 
experimental conditions, possibly because of strong sorption to the glass surface of the bottle 
and/or the water surface. These APIs were Amiodiarone, Bromocriptine, Chlorpromazine, 
Clemastine, Dihydroergotamin, Fluphenazine, Levomepromazine, Meclozine, Miconazole, 
Perphenazine, Prometazine, Roxithromycine and Tamoxifen.  
The experimental design of the present study and the LOQ in the present matrixes for the 
individual APIs measured, provides the limits of Kd. The highest Kd that could be obtained 
within the concentration range 0.08 – 10 µg L-1 and given the median LOQ, 8 ng L-1 was 1.2 
×106 L kg-1. However, if the LOQ was low (1 ng L-1) or high (170 ng L-1), the highest Kd could 
be expected within the range from 5×104 to 1×107 L kg-1. Furthermore, assuming that at least 
10% was required to be sorbed in order to determine a Kd value the lowest Kd value obtained 
within the present study was 100 L kg-1. 
Thirteen of the APIs exhibited so low sorption on the sludge that a sorption isotherm was 
impossible to determine. The low sorbing APIs were Buprenorphine, Cilazapril, Carbamazepine, 
Codeine, Diclofenac, Estrone, Flecainide, Fluconazole, Metoprolol, Naloxone and 
Rosuvastatine, Tramadol and Venlafaxine in all three sludge. For the following APIs their 
sorption vary between each type of sludge. APIs which specifically exhibited low sorption for 
the primary sludge were Bisoprolol, Diltiazem, Eprosartan, Estradiol, Ibuprofen, Levonorgestrel, 
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Medroxyprogesterone, Orphenadrine and Sotalol. The obtained Kd values for the APIs above 
ranged in the two secondary sludge between 71 and 740 L kg-1 (Table 3 and 4). APIs which 
specifically exhibited low sorption for the sludge with short sludge age were Alfuzosin, 
Citalopram, Clonazepam, Donepezil and Eprosartan. Finally for the secondary sludge with long 
sludge age the low sorbing APIs were the APIs Clonazepam and Diltiazem, generally the Kd 
values obtained for these APIs were low in the other sludge types.  
Several of the Kd values obtained in other studies would in comparison with the present study be 
below or around the lowest Kd values that could be obtained. Examples of such APIs are 
Codeine (Wick et al., 2009) and Estrone, (Andersen et al., 2005; Carballa et al., 2008). Further 
low Kd values were reported by Ternes et al. (2004) with Carbamazepine in primary and 
secondary sludge <20 and 1.2 L kg-1 and Ibuprofen <20 and 7.1 L kg-1, respectively. Results 
from Carballa et al. (2008) and Joss et al., (2005) supported these findings. Abegglen et al., 
(2009) reports Kd values from experiments with secondary sludge from membrane bioreactors 
for Carbamazepine and Ibuprofen which both were found to have low sorption (<75 L kg-1). 
Calculated Kd values for primary and secondary sludge were in the same range for Ibuprofen 9.5  
and 0 L kg-1, respectively, whereas for Carbamazepine they were 10 to 100 times higher  (314 
and 135 L kg-1; Radjenović et al., 2009). Urase and Kikuta (2005) evaluated the sorption and 
degradation of APIs. Two of the APIs included were Ibuprofen and Carbamazepine, which were 
found to have Kd values of 80 and 66 L kg-1, respectively at pH 6.7 (Urase and Kikuta; 2005).  In 
the present study Ibuprofen had a weak sorption in the two secondary sludge, which resulted in 
low Kd values, 200 and 360 L kg-1, obtained from the short and long sludge age, respectively, the 
reason may be due to the differently performed experiments. Contrary to the present study 
Ternes et al. (2004) report for Diclofenac the Kd value 459 L kg-1 for primary sludge which is 
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within the limits of the present study but no sorption isotherm could be obtained,  whereas for 
secondary sludge the authors report 16 L kg-1 which was outside the limits for the present study. 
Also Joss et al., (2005) report values for Diclofenac in the same range for both sludges. Carballa 
et al. (2008) reported values ranging between 19-158 L kg-1 which would be out of the limits for 
the present study. Radjenović et al. (2009) calculated the Kd value for Diclofenac for primary 
and secondary sludge at 194 and 118, respectively. Based on this, Diclofenac appears to have 
higher affinity for the primary sludge. One explanation could be the difference in pH values 
(Ternes et al., (2004)). However, in the present study Diclofenac was not among those APIs for 
which pH was affecting its sorption (see below section 3.4 and Table 5). The Kd values obtained 
in this study for Sulfamethoxazole (Table 2 to 4) were in the same order as those reported in 
Göbel et al. (2005) for activated sludge. Abegglen et al., (2009) and Carballa et al., (2009) found 
the Kd of Sulfamethoxazole to be one order of magnitude lower compared to the present study, 
and Radjenović et al. (2009) reported two order of magnitude lower Kd values. Another 
contradictory study of Sulfamethoxazole come from Wu et al. (2009) whom claimed sorption to 
be too weak, but also reported Kd for other antibiotics in the same level as found here for 
Sulfamethoxazole.  Sulfamethoxazole has been reported to be photosensitive (e.g. Zhou and 
Moore, 1994; Trovó et al., 2009; Ryan et al., 2010). In the present study precautions were taken 
against photo-degradation. Depending on how different sorption studies have been carried out 
and precautions taken against photo-degradation throughout the whole experiment, including the 
extracts, photo-degradation might be an explanation to the diverging Kd results. The Kd values 
obtained in this study for Trimetoprim (Table 2 to 4) were in the same order as those reported in 
Göbel et al. (2005) for activated sludge. Also Radjenović et al. (2009), and Abegglen et al., 
(2009) found Kd for Trimetoprim to be in the same order of magnitude.  The Kd obtained by 
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Radjenović et al. (2009) for Atenolol and Glibenclamide was one order of magnitude lower 
compared to those presented in this study (Table 2 to 4). In addition, Maurer et al (2007) 
obtained even lower Kd values below 40 L kg-1 for Atenolol, Sotalol, Metoprolol. 
Roxythromycin was included in the study conducted by Abegglen et al., (2009) where the 
authors determined Kd to be 570 L kg-1 which is almost 6 times higher than the one reported by 
Ternes at al., (2004). In the present study Roxythromycin was among those APIs for which no 
sorption isotherm could be obtained.    However, the main differences were found between 
primary and secondary sludge and not between the two secondary types of sludge. It may 
therefore be assumed that the explanation can be derived from the origin of the sludge type. 
Primary sludge originate from particles found in wastewater e.g. much of it is derived from toilet 
paper and other plant matter found in food waste and secondary sludge mainly contains settled 
bacteria and biopolymers created by the bacteria. Based on the origin of the sludge it is likely 
that the sorption of different APIs structures can vary between the sludge types.  
Influence of temperature on sorption is not well studied and the temperature may not always be 
reported in sorption studies. The effect of temperature was studied by Zeng et al., (2009) who 
found the difference in Kd between 10, 20 and 30 °C was 20-25%. The Kd values obtained in the 
present study may thus have somewhat higher Kd-values in comparison with other studies 
conducted at 10 or 20  ̊C.  
3.4 Effect of pH on sorption 
In the present study, 20 out of 50 APIs were found to have a significant difference in their mean 
Kd values obtained in the secondary sludge with long sludge age between  pH values 6, 7 and 8 
(Table 5). By employing one way ANOVA-test, with   Tukeys post-test at 95 % confidence 
level, the significant difference within the pH range of WWTPs was determined and identified. 
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All structures of the APIs, where the ANOVA-test indicated a significant difference between Kds 
included a nitrogen atom and in many case an amine functional group and hence had basic 
properties. Even though the Kd values were significantly different in the pH range 6 to 8, it will 
not have any significant effect on the removal via sorption to sludge (in a subsequent appendix 
Table A1). However, Chlorpramine, Chloprothixene, Duloxetine, Fluoxetine, Levomepromazine, 
Loperamide, Nefazedone and Sertraline were exceptions. For these APIs the pH variation from 6 
to 8 affected the fraction in the liquid phase by 10-20% (in a subsequent appendix Table A1). 
These APIs can be assumed to be weak bases. Carballa et al., (2008) point out that it has to be 
considered whether the pH value will affect sorption, as an example for Diclofenac (pKa 4.15). 
In the current study the variation of pH did not significantly affected the Kd. for Diclofenac even 
though pH was 2 to 4 pH units higher than the pKa. Fluoxetine (pKa 9.6) was in the current study 
shown to be affected by the pH, the difference between pKa and the investigated pH was 2 to 4 
pH units. Even though the differences between pKa for Diclofenac and Fluoxetine was in the 
same range the two APIs showed different influence by changes of the pH. An investigation of 
the effect of pH on Naproxen and Carbamazepine, found the highest sorption was at pH 4, and 
no significant difference occur between pH values 6 and 8 (Maoz and Chefetz, 2010).  Further 
investigation of the particulate fraction of the sludge found the overall pKa to be 6.1 (Wang et 
al., 2000). The present study was conducted at a pH value above the pKa for sludge.  It cannot be 
excluded that the Kd was affected by changes caused by pH both in the API structure and the 
structure of the sludge since among the studied compounds were APIs containing N-groups. The 
APIs which did not show a significant difference in the Kd-values within the pH range 6 to 8 can 
be expected to be stable in their ionized and neutral form, respectively.  
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Table 5. Evaluating the effect of pH within the pH rang for a WWTP, pH 6-8. Average one point Kd values with 
standard deviation (n=3) obtained in sludge from secondary sludge long sludge age at pH 6, 7 and 8for the 
concentration 10 µg L-1. By employing one way ANOVA with a 95 % confidence interval was the following 
question asked; are the means significantly different?  
 Average Kd P<0,05? 
 pH 6-8 pH 6 pH 7 pH 8 pH 6-8 
Alfuzosin 1.0 ±- 0.2×103 12 ±0.4×102 7.3 ± 0.3×102 11 ± 0.5×102 no 
Amitryptiline 2.8 ± 1.0×103 2.8 ± 0.2×103 1.8 ± 0.3×103 4.0 ± 0.7×103 yes 
Atenolol 1.6 ± 0.2×103 1.6± 0.2×103 1.6 ± 0.2×103 16 ± 0.9×102 no 
Atracurium 4.1 ± 0.6×102 4.7 ± 0.2×102 413 ± 20×103 3.4 ± 0.2×102 yes 
Azelastine 1.7 ± 0.7×103 2.0 ± 0.1×103 8.7 ± 0.5×102 2.3 ± 0.1×103 yes 
Biperiden 0.8 ± 0.2×103 7.6 ± 0.9×102 0.6 ± 0.1×103 1.0 ± 0.2×103 no 
Bisoprolol 1.2 ± 0.9×102 0.6 ± 0.6×102 2.1 ± 0.9×102 0.8 ± 0.4×102 no 
Bupropion 1.4 ± 0.1×102 1.4 ± 0.1×102 1.4 ± 0.2×102 1.5 ± 0.2×102 no 
Chloprothixene 1.9 ± 0.8×104 2.0 ± 0.1×104 10 ± 0.7×103 2.8 ± 4.6×104 yes 
Clomipramine 6.6 ± 2.4×103 6.7 ± 0.2 ×103 3.9 ± 0.2×103 9.3 ± 1.1×103 yes 
Clotrimazol 3.6 ± 0.5×104 3.6 ± 0.5×104 3.3 ± 0.4×104 4.0 ± 0.4×104 no 
Cyproheptadine 3.4 ± 1.0×103 3.6 ± 0.2×103 2.1 ± 0.1×103 4.4 ± 0.3×103 yes 
Desloratidine 2.9 ± 0.5×103 2.9 ± 0.2×103 2.3 ± 0.2×103 3.4 ± 0.3×103 no 
Diclofenac 0.8 ± 0.4×103 8.0 ± 0.6×102 4.8 ± 81×102 1.2 ±0. 6×103 no 
Dicycloverin 1.8 ± 0.6×103 1.7 ± 0.2×103 1.2 ± 0.3×103 2.4 ±0.5 ×103 no 
Donepezil 0.8 ± 0.3×103 9.6 ± 0.1×102 4.8 ± 0.3×102 10 ± 0.4×102 no 
Duloxetine 3.0 ± 1.2×103 2.9 ± 0.1×103 1.8 ± 0.3×103 4.4 ± 0.7×103 yes 
Eprosartan 0.6 ± 0.7×102 0.5 ± 0.4×102 0.6 ± 0.9×102 0.8 ± 1.0×102 no 
Estradiol 0.3 ± 0.2×103 0.4 ± 0.3×1023 0.2 ± 0.9×102 4.2  ± 0.7×102 no 
Ezetimibe 3.3 ±0. 6×103 3.2  ± 0.3×103 3.0 ± 0.6×103 3.9 ± 0.7×103 no 
Fexofenadine 2.7 ± 1.4×102 3.6 ±0. 8×102 3.5 ± 0.5×102 1.0 ± 0.9×102 yes 
Fluoxetine 6.2 ± 2.3×103 6.1 ± 0.4×103 3.7 ± 0.7×103 8.7 ± 1.6×103 yes 
Flutamide 0.8 ± 0.1×103 0.8 ± 0.1×103 0.8 ± 0.1×103 0.6 ± 0.1×103 no 
Glibenclamide 1.2 ± 0.2×103 1.4 ± 0.1×103 1.1 ± 0.1×103 1.1 ± 0.1×103 yes 
Glimepiride 9.4 ± 0.8×102 9.6 ± 0.8×102 0.9 ± 0.1×103 964 ± 12 no 
Haloperidol 2.3 ±0.8×103 2.9 ±0.2×103 1.2 ±0.1×103 28 ± 0.3×102 no 
Hydroxyzine 0.5  ± 0.2×103 7.1 ± 0.9×102 5.3 ± 1.0×102 0.3 ± 0.1×103 yes 
Irbesartan 0.3 ± 0.5×103 0.9 ± 0.2×103 1 ± 0 14 ± 2 yes 
Levomepromazine 2.5 ± 1.5×103 2.4 ± 70.×103 1.0 ± 0.3×103 4.2 ±0.1×103 yes 
Levonorgestrel 0.1 ± 0.2×103 2.5 ± 0.6×102 7 ± 193 0.2 ± 0.1×103 no 
Loperamide 5.4 ± 2.0×103 5.7 ± 0.6×103 3.0 ± 0.3×103 7.3 ± 1.2×103 no 
Maprotiline 4.5 ± 1.7×103 4.6 ± 0.4×103 2.7 ± 0.4×103 6.2 ± 1.2×103 no 
Medroxyprogesterone 0.1 ± 0.1×103 0.2 ± 0.1×103 -0.2 ± 0.8×102 0.2 ± 0.1×103 no 
Megestrol 0.5 ±0.3×103 0.6 ± 0.2×103 0.3 ± 0.2×103 0.7 ± 0.2×103 no 
Mianserin 0.6 ± 0.2×103 9.1 ± 0.9×102 404 ± 0.3×102 6.2 ± 0.3×102 yes 
Nefazodone 6.4 ±2.2×103 8.8 ± 1.1×103 6.3 ± 0.9×103 4.2 ± 0.9×103 yes 
Orphenadrine 0.7 ± 0.2×103 6.5 ± 0.5×102 5.0 ±0.5 ×102 8.2 ± 0.9×102 yes 
Oxazepam 1.5 ± 0.4×103 1.1 ± 0.2×103 1.9 ± 0.2×103 1.6 ± 0.3×103 no 
Paroxetine 8.2 ± 3.0×103 8.5 ± 1.2×103 4.9 ± 0.8×103 11 ± 2.0×103 no 
Pizotifen 3.1 ± 1.0×103 3.1 ± 0.2×103 2.0 ± 0.2×103 4.3 ± 0.6×103 yes 
Progesterone 1.0 ±0.4×103 1.1 ± 0.3×103 0.6 ± 0.1×103 1.3 ± 0.2×103 no 
Repaglinide 0.1 ± 0.1×103 0.1 ± 0.1×103 0.2 ± 0.1×103 0.7 ± 1.2×102 no 
Risperidone 0.6 ±0.1×103 6.5 ± 0.6×102 4.2 ± 0.4×102 6.2 ± 0.3×102 no 
Sertraline 1.8 ± 0.7×104 1.8 ± 0.2×104 9.8 ± 0.7×103 2.6 ± 0.4×104 yes 
Sotalol 3.0 ± 0.6×102 4.0 ± 0.3×102 2.4 ±  0.5×102 3.0 ± 0.2×102 no 
Sulfamethoxazol 0.3 ± 0.1×103 0.3 ± 0.2×103 0.3 ± 0.1×103 2.7 ± 0.8×102 no 
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Telmisartan 0.8 ± 0.4×103 1.0 ± 0.1×103 0.9 ± 0.4×103 0.4 ± 0.2×103 no 
Trimetoprim 3.5 ± 0.7×102 4.3 ± 0.3×102 348 ± 9 2.8 ± 0. 2×102 yes 
Venlafaxine 0.5 ± 0.6×102 1.0 ± 0.4×102 -6 ± 21 0.6 ± 0.4×102 no 
Verapamil 4.0 ± 0.8×102 3.8 ± 0.7×102 3.6 ± 0.8×102 0.4 ± 0.1×103 yes 
 
3.5 Correlation of sorption with Kow 
An illustration of the absence of correlation between log Dow (calculated) and log Kd-values is 
shown in Figure 2. The calculation of log Dow was based on calculated values of log Kow using 
KOWIN and calculated pKa values presented by Manallack (2009).  Log Dow was for acidic 
compounds calculated according to Dow=Kow+1/(1+10(pH-pKa)) and for basic compounds 
Dow=Kow+(1/(1+10(pKa-pH)). To estimate the sorption behavior based only on log Dow gives an 
incorrect sequence when compared and put in relation to other compounds. A few examples to 
illustrate the difficulties include Atenolol log Kd 3.6 and log Dow -2.6 and Bisoprolol log Kd 3.1 
and log Dow -0.7, with the calculated pKa 9.6 and 9.5, respectively. However, using log Dow to 
predict the tendency of sorption for Glimpiride and Ibuprofen with the log Dow 2.7 and 2.0, 
respectively, using pKa 5.0 and 4.3, respectively would give the impression that Glimperide 
could be expected to have higher affinity to sludge than Ibuprofen. The experimentally 
determined log Kd (3.0 and 2.6, respectively) values obtained in the present study confirm such a 
hypothesis. However, applying the same hypothesis for Estradiol and Ezetimibe with the same 
log Kow 3.94 but with respect to pKa (9.72 and 10.3) the log Dow would be 0.67 and 1.22, 
respectively, the tendency would be that Ezetimibe would have higher affinity to sludge. But the 
results from the present study imply the opposite, log Kd 2.47 and log Kd-1.98, respectively. 
Even though efforts have been made to calculate the Kd based on Kow with respect to pKa values, 
the inherent properties of the APIs and the sludge will need multiple descriptors to get close to 
experimentally derived Kd-values.  
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Figure 2. The plot illustrates that for majoring of the APIs in this study it was not possible estimate their sorption 
behavior based on log Dow.  
 
3.7 Consequence of sorption for the fate of APIs 
In order to estimate the removal (see Materials and methods 2.5) of APIs that were not lost from 
degradation or stripping but due to sorption in the WWTP process, the obtained Kd values were 
employed to estimate the fraction of API in the water phase (see Fig. 3; Table S4). The Kd values 
obtained from the primary sludge and secondary sludge with long sludge age were used for the 
estimation. However, the difference from the other secondary sludge was not larger than 6 
percentage points with the median at 4 percentage points. Therefore, the results can be 
considered to be similar. Figure 3 presents the predicted distribution between the water and 
sludge of APIs based on the determined Kds and selected typical primary and secondary sludge 
outputs from the WWTP. All APIs detected, and hence the APIs for which no sorption isotherms 
were determined are included (both those with too low sorption and those with too strong 
 sorption for the experimental design used). 
in the water phase at >80%. For 15 of the APIs
water phase was 20% or less. For 13 of those, sorption was too strong that isotherms were not 
obtained. The estimated water fraction for the APIs showed that they could be distributed from 
100 % in the water phase to 13% in the water phase (see 
Earlier investigations of APIs removal in activated sludge (Göbel et al., 2005) distinguished 
between different treatments steps in the WWTP. For Sulfamethoxazole and Trimetoprim the 
API removed by sorption can be compared with the present study. Göbel et al. (2005) found 
1.5% and 4% as total removal of these compounds to primary and secondary sludge, 
respectively. The removal of those compounds was in this study approximately 10% 
for both APIs. Ra et al. (2008) presents the removal for Estradiol, Diclofenac and Ibuprofen 
which were in the same range as in the present study, see Figure 3.
Figure 3. Estimated fraction, i.e. the fraction of the total APIs load into the activated sludge tank 
which isn’t lost either by degradation or stripping,
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Figure 3 includes 37 APIs which mainly are present 
, the sorption was so strong that the fraction in the 
Fig. 3).  
 
 of the API in the water phase 
(see Fig. 3) 
 
based on 
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experimentally determined sorption isotherms obtained by using primary and secondary sludge. 
For further information see supplementary data Figure S1. 
 
4. Conclusion  
In this study experimentally derived sorption isotherms are presented along with the 
corresponding obtained Kd values. The obtained Kd values were used in order to estimate the 
removal of the APIs in the WWTPs due to sorption to sludge. 
The major findings from this study are:  
• Experimentally derived Kd values and sorption isotherms for 52 APIs.  
• For 13 APIs sorption to sludge was stronger than 1.2 ×106 L kg-1  
• For 10 APIs sorption to sludge was less than 100 L kg-1. 
• The estimation of removal due to sorption (in the absence of degradation and stripping) 
demonstrated that for 31 APIs were fractioned >80% of the initial concentration would be 
recovered in the liquid phase.  
• 15 APIs have high affinity towards the sludge, i.e. <20% of the initial concentration 
would be found in the liquid phase. These APIs will therefore mainly be removed from 
the wastewater with the sludge, unless they are biodegraded significantly during 
treatment. 
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Supplementary information 
 
S1. Supplementary information regarding sample extraction and analyses using LC-
MS/MS.  
The filters used in order to remove particles from the water phase were rinsed once in MeOH 
followed by deionized water before use. The filtered samples were adjusted to pH 3 with a strong 
phosphate buffer. As surrogate standards, a mixture of 13 13C and 2D labelled APIs was 
employed, containing Amytriptyline, Carbamazepine, Ciprofloxacin, 17β-Ethinylestradiol (EE2), 
Fluoxetinee, Ibuprofen, Oxazepam, Promethazinee, Risperidone, Sulfamethoxazole, Tamoxifen, 
Tramadol and Trimetoprim. The samples were extracted employing solid phase extraction (SPE), 
Oasis HLB 6cc/200 mg, 30µm (Waters, Sweden). Before loading the samples, the cartridges 
were solvated and conditioned as follows; 5 mL EtAc followed by 5 mL MeOH and 5 mL 
acified water pH 3. The cartridges were freeze dried over night and thereafter stored in a freezer 
at -20ºC until analysis was performed. The cartridges were eluted with 5 mL MeOH followed by 
2 mL EtAc, extracts were evaporated to dryness and the solvent was changed to 30 % MeOH 
with 0.1 % formic acid before analysis by LC-MS/MS. The same methodology as that reported 
in Grabic et al. (unpublished data), Fick et al., (2009) was used for this analysis. Hence, detailed 
information on chromatographic settings, mass transitions, collision energies, scan times, mass 
spectrometric settings, etc. can be found there. In short, a triple stage quadrupole MS/MS TSQ 
Quantum Ultra EMR (Thermo Fisher Scientific, San Jose, CA, USA) coupled with an Accela LC 
pump (Thermo Fisher Scientific, San Jose, CA, USA) and a PAL HTC autosampler (CTC 
Analytics AG, Zwingen, Switzerland) were used as analytical system. 20 µL of the sample was 
loaded onto a Hypersil GOLD aQ TM column (50 mm x 2.1 mm ID x 5 µm particles, Thermo 
Fisher Scientific, San Jose, CA, USA) preceded by a guard column. A gradient of flow and 
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MeOH and ACN in water (all solvents buffered by 0.1% formic acid) was used for elution of 
analytes. Both heated electrospray (HESI) and atmospheric pressure photoionization (APPI) in 
positive and negative ion modes were used for ionisation of target compounds. Both first and 
third quadrupoles were operated at resolution 0.7 FMWH, and two or three selected reaction 
monitoring (SRM) transitions were monitored for each analyte. SRM is an analogue to the more 
common monitoring method, single ion monitoring (SIM) in standard mass spectrometry. With 
SRM, the ion monitored in the first step is required to form a given fragment through a selected 
reaction in order to be positively identified. Samples were quantified using the SRM method. 
Several calibration standards covering all concentration ranges were measured before, in the 
middle and at the end of sample sequences. The maximum difference between results at 
quantification and qualification mass transition was set to 30% as criterion for positive 
identification. 
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Table S1 NOMENCLATURE  
 
 
 
 
API active pharmaceutical ingredient 
atmospheric pressure photoionization 
measured concentrations of API in the water phase without sludge  
calculate concentration of APIs sorbed to the sludge 
measured concentrations of API in the water phase 
dissolved organic matter 
glass microfiber filter 
heated electro spray ionisation 
distribution coefficient 
distribution coefficient dissolved organic carbon 
liquid chromatography coupled with tandem mass selective detector 
limit of quantification 
Freundlich exponent 
person equivalents 
single ion monitoring 
solid phase extraction 
selected reaction monitoring 
suspended solids 
mass of the sludge removed 
the total number of surface sites per mass of sorbent 
volatile suspended solid 
APPI 
C0 
Cs 
Cw 
DOM 
GC/F 
HESI 
Kd 
KDOC 
LC-MS/MS 
LOQ 
n 
PE 
SIM 
SPE 
SRM 
SS 
RESS 
τmax 
VSS 
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Table S2. Presenting the APIs included in the present study and the calculated Henry’s Law constant (KH; Atm m3 
mol-1) 
Alfuzosin 9.5×10-20 Dihydroergotamine 1.1×10-26 Medroxyprogesterone 1.3×10-8 
Amiodarone 1.8×10-12 Diltiazem 8.6×10-17 Metoprolol 1.4×10-13 
Amitriptyline 6.8×10-8 Donepezil 1.2×10-12 Mianserin 8.1×10-10 
Atenolol 1.4×10-18 Duloxetine 5.4×10-10 Miconazole 2.4×10-9 
Atracurium 2.0×10-35 Eprosartan 5.6×10-17 Naloxone 5.4×10-19 
Azelastine 2.6×10-13 Estradiol 3.6×10-11 Nefazodone 1.5×10-17 
Biperiden 2.5×10-10 Estrone 3.8×10-10 Orphenadrine 4.1×10-9 
Bisoprolol 2.9×10-15 Ezetimibe 4.4×10-18 Oxazepam 5.5×10-10 
Bromocriptine 1.1×10-25 Fexofenadine 1.2×10-18 Paroxetine 1.1×10-11 
Buprenorphine 7.8×10-18 Fecainide 5.8×10-13 Perphenazine 5.2×10-18 
Bupropion 1.0×10-7 Fluconazole 1.0×10-13 Pizotifen 2.6×10-8 
Carbamazepine 1.1×10-10 Fluoxetine 8.9×10-8 Progesterone 6.5×10-8 
Chlorpromazine 3.7×10-10 Fluphenazine 6.1×10-17 Promethazine 5.0×10-10 
Chlorprothixene 2.5×10-9 Flutamide 3.7×10-10 Repaglinide 1.3×10-17 
Cilazapril 1.8×10-18 Glibenclamide 7.6×10-19 Risperidone 2.2×10-16 
Citalopram 2.7×10-11 Glimepiride 1.4×10-21 Rosuvastatin 1.5×10-16 
Clemastine 3.8×10-9 Haloperidol 2.3×10-14 Roxithromycin 5.0×10-31 
Clomipramine 7.5×10-9 Hydroxyzine 3.9×10-17 Sertraline 5.1×10-8 
Clonazepam 7.0×10-13 Ibuprofen 1.5×10-7 Sotalol 2.5×10-14 
Clotrimazole 3.1×10-8 Irbesartan 7.0×10-15 Sulfamethoxazole 9.6×10-13 
Codeine 7.6×10-14 Levomepromazine 3.9×10-11 Tamoxifen 4.5×10-10 
Cyproheptadine 9.2×10-9 Levonorgestrel 7.7×10-10 Tramadol 1.5×10-11 
Desloratadine 2.1×10-11 Loperamide 6.9×10-19 Trimethoprim 2.4×10-14 
Diclofenac 4.7×10-12 Maprotiline 8.0×10-8 Venlafaxine 2.0×10-11 
Dicycloverine 8.9×10-7 Meclozine 4.6×10-12 Verapamil 8.8×10-15 
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Table S3. Sorption isotherms obtained during sorption to secondary sludge short sludge age, including 1, 10 and 50 
g sludge. P is the significance that the linear model has a better fit than another model tested, the model tested was 
Freundlich and Langmuir.  
 Linear Freundlich Langmuir 
 Kd R² 
(%) 
Kf n R² 
(%) 
P 
(%) 
τMAX KL R2 
(%) 
P 
(%) 
Alfuzosin 3.5×102 73 1.2×10-5 0.4 98 0.23 no fit    
Alprazolam 3.1×102 55 1.6×10-8 0.3 77 0.25 no fit    
Amitryptiline 2.7×103 91 3.3×10-2 0.6 98 0.01 no fit    
Atracurium 5.5×102 89 1.5×10-3 0.6 98 0.01 no fit    
Azelastine 1.4×103 96 9.4×10-2 0.8 97 0.72 no fit    
Biperiden 8.0×102 91 2.9×10-2 0.7 95 0.52 no fit    
Bromocriptine 7.7×103 75 5.4×10-6 0.3 92 0.01 no fit    
Buprenorphine 9.6E+01 71 no fit    no fit    
Bupropion 1.9×102 96 2.6×10-2 0.8 97 0.60 no fit    
Chlorpromazine 8.8×103 72 3.9×10-8 0.2 94 0.01 no fit    
Clemastine 7.6×103 91 3.2×10-2 0.6 97 0.02 no fit    
Clomipramine 7.1×103 86 1.4×10-2 0.5 97 0.01 no fit    
Clonazepam 2.9×102 66 no fit    no fit    
Cyproheptadine 5.3×103 97 0.4 0.7 99 0.01 no fit    
Desloratidine 3.0×103 90 2.9×10-2 0.6 97 0.01 no fit    
Dicycloverin 1.7×103 95 9.0×10-2 0.7 98 0.05 no fit    
Diltiazem 4.2×102 96 3.4×10-2 0.8 98 0.15 no fit    
Duloxetine 3.2×103 84 2.6×10-5 0.4 97 0.01 no fit    
Estradiol 2.3×102 70 0.3 1.0 70 87 1.4×104 1.8×10-5 71 75 
Etonogestrel 2.4×102 72 0.4 1.1 72 80 1.2×104 2.3×10-5 72 78 
Ezetimibe 8.5×103 87 7.2 1.0 87 89 no fit    
Fexofenadine 6.6×102 93 2.7×10-3 0.6 98 0.03 no fit    
Finasteride 8.1×102 77 no fit    no fit    
Fluoxetine 5.3×103 86 3.8×10-3 0.5 99 0.01 no fit    
Flutamide 1.2×103 94 1.7×10-2 0.7 97 0.21 no fit    
Glibenclamide 2.2×103 93 3.2×10-2 0.7 97 0.03 no fit    
Haloperidol 1.7×103 98 no fit    no fit    
Hydroxyzine 5.9×102 93 0.1 0.8 94 6.9 no fit    
Levomepromazine 3.8×103 96 0.3 0.7 99 0.02 no fit    
Loperamid 1.1×104 91 0.3 0.7 95 0.58 no fit    
Maprotiline 3.7×103 89 7.9×10-2 0.7 95 0.06 no fit    
Medroxyprogesterone 2.5×102 92 0.6 1.1 92 41 1.3×104 2.1×10-5 92 64 
Megestrol 8.2×102 86 0.2 0.9 86 39 no fit    
Mianserin 5.3×102 91 0.6 1.0 91 88 no fit    
Nefazodone 8.8×103 92 7.4×10-2 0.6 98 0.01 no fit    
Orphenadrine 4.8×102 87 2.1×10-3 0.6 93 0.09 no fit    
Oxazepam 1.6×103 95 no fit    no fit    
Paroxetine 8.1×103 79 1.9×10-4 0.4 97 0.01 no fit    
Pizotifen 3.0×103 97 0.2 0.7 99 0.01 no fit    
Progesterone 1.0×103 95 0.2 0.8 96 3.3 no fit    
Promethazine 2.8×103 89 3.2×10-2 0.6 96 0.03 no fit    
Sotalol 7.1×102 95 6.3×10-2 0.8 98 0.09 no fit    
Telmisartan 5.8×102 70 no fit    no fit    
Trihexyphenidyl 6.8×102 83 5.8×10-4 0.6 92 0.04 no fit    
Trimetoprim 2.6×102 91 3.4×10-3 0.7 97 0.01 no fit    
Zolpidem 1.4×102 91 no fit    no fit    
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Table S4. Based on the best fitted sorption isotherms for each API and the removal of sludge in a Swedish average 
WWTP the fraction of the APIs passing through the WWTP was calculated. In the case were the linear isotherm 
were not the best fitted a Kd value was calculated assuming an water concentration of 1µg L-1. FwP = Primary sludge 
water fraction, FwS= Secondary sludge water fraction and FwT=total fraction in water.  
 Primary 
sludge 
Secondary 
sludge 
long 
sludge age 
FwP 
(%) 
FwS 
(%) 
FwT 
(%) 
Afluzosin Linear Langmuir 73 86 63 
Amitryptiline Linear Linear 54 77 41 
Atenolol Linear Langmuir 91 70 64 
Atracurium Linear Linear 93 95 89 
Azelastine Langmuir Linear 29 82 24 
Biperiden Linear Linear 85 92 79 
Bupropion Freundlich Linear 100 98 98 
Chloprothixene Linear Linear 97 32 31 
Citalopram Linear Linear 90 98 88 
Clomipramine Linear Freundlich 22 91 20 
Clotrimazol Linear Freundlich 13 100 13 
Cyproheptadine Linear Linear 31 72 22 
Desloratidine Linear Linear 56 76 42 
Dicycloverin Linear Linear 77 84 65 
Donepezil Linear La 57 86 49 
Duloxetine Linear Linear 28 76 21 
Ezetimibe Freundlich Freundlich 100 100 100 
Fexofenadine Linear Linear 100 96 96 
Fluoxetine Freundlich Freundlich 96 99 95 
Flutamide Linear Freundlich 77 100 77 
Glibenclamide Linear Linear 57 87 50 
Glimepiride Freundlich Linear 100 90 90 
Haloperidol Linear Linear 31 76 24 
Hydroxyzine Linear Linear 80 93 74 
Irbesartan Linear Freundlich 87 100 87 
Loperamide Freundlich Freundlich 100 100 100 
Maprotiline Freundlich Freundlich 98 100 97 
Mianserin Linear Linear 61 91 56 
Nefazodone Freundlich Linear 98 52 51 
Oxazepam Linear Linear 86 89 76 
Paroxetine Linear Freundlich 25 100 25 
Pizotifen Linear Linear 51 75 38 
Progesterone Linear Linear 86 89 77 
Repaglinide Linear Langmuir 97 92 89 
Risperidone Linear Langmuir 72 90 65 
Sertraline Freundlich Freundlich 100 100 100 
Sulfamethoxazol Linear Linear 94 96 90 
Trimethoprim Linear Linear 92 96 88 
Verapamil Linear Langmuir 72 86 63 
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Figure S1. 
 
Figure S1. Estimated fraction, i.e. the fraction of the total APIs load into the activated sludge tank 
which isn’t lost either by degradation or stripping, of the API in the water phase based on experimentally 
determined sorption isotherms. ) experimentally determined Kds for primary and secondary sludge; ) 
experimentally determined Kds for the primary sludge and assuming no sorption to the secondary sludge as sorption 
were too low to be obtained in the present experiment; ) experimentally determined Kds for the secondary sludge 
and assuming no sorption to the primary sludge as sorption were too low to be obtained in the present experiment; 
) assuming no sorption to neither one of the sludges as the sorption were too low to be obtained in the present 
experiment; ) assuming high sorption due to too high sorption in the present study. 
 
 
